Here are three things to know.
1. The Trevo Retriever is a small, stent-shaped medical device used to remove blood clots.
2. Clinicians may now use the device as a first-line treatment for patients experiencing acute ischemic stroke for up to 24 hours after symptom onset. Previously, the device could only be used for up to six hours after symptoms first appear.
3. The Trevo Retriever is the first thrombectomy device approved with a 24-hour treatment window.
More articles on supply chain:
Amazon quietly launches exclusive OTC product line: 7 things to know
AbbVie, Voyager ink $69M deal to develop Alzheimer’s drug
Roche’s diabetes app recalled over software bug: 4 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.